EXECUTIVE BOARD
Dr. Henri Michael von Blanquet, M.D., MaHM (Founder)
ADVISORY BOARD
Dr. Scott Kahn, PhD – former Chief Information Officer of illumina
Dr. Razelle Kurzrock, M.D, Director, Center for Personalized Cancer Therapy and Clinical Trials Office & Senior Deputy Director for Clinical Science, Moores Cancer Center & Chief, Division of Hematology-Oncology, Department of Medicine
Dr. Erwin Boettinger, M.D., PhD, Head & Professor “Digital Health & Precision Medicine”, Faculty of Digital-Engineering of Hasso-Plattner-Institute and University of Potsdam
Dr. Thomas Gottwald, M.D., PhD, Professor of Surgery – Exceutive Board Ovesco AG
Dr. Clemens Guth, M.D., MBA – Managing Director Artemed Hospital Group
Dr. Norbert Klusen, Professor – former CEO of Techniker Krankenkasse
BOARD OF EXPERTS
Gabriel A. Bien-Willner, M.D., PhD, FCAP – Founder Bien-Willner Physicians Group for Molecular Diagnostics (USA)
BOARD OF TRUSTEES AND INVESTORS
Dr. Antonius Schuh, PhD, Founder Global Source Ventures, LLC
N.N.
PROFIT AND NON-PROFIT PARTNERS
Roger Sturm, CEO QB-International
Alois Steidel, CEO KMS Vertrieb und Services AG, Board of Directors cdgw.de
FRIENDS OF THE PRECISION MEDICINE ALLIANCE
